Hans J. W. de Haard
Corporate Officer/Principal at University of Utrecht
Profile
Hans J. W. de Haard founded argenx SE and AgomAb Therapeutics NV. Currently, he holds the position of Chief Scientific Officer at argenx SE. He is also Professor at Université de Franche-Comté and Professor-Camelid Immunology at the University of Utrecht. He previously was Scientist at Unilever NV and Director-Technology Development at Ablynx NV. Dr. De Haard received a doctorate and a graduate degree from Maastricht University.
Hans J. W. de Haard active positions
| Companies | Position | Start |
|---|---|---|
| University of Utrecht | Corporate Officer/Principal | - |
| Université de Franche-Comté | Corporate Officer/Principal | - |
Former positions of Hans J. W. de Haard
| Companies | Position | End |
|---|---|---|
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Founder | - |
| ARGENX SE | Founder | - |
| UNILEVER N.V. | Chief Tech/Sci/R&D Officer | - |
| ABLYNX | Chief Tech/Sci/R&D Officer | - |
Training of Hans J. W. de Haard
| Maastricht University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Private companies | 3 |
|---|---|
Unilever NV
 Unilever NV Food DistributorsDistribution Services Unilever NV engages in the production and marketing of consumer goods in the nutrition, hygiene, and personal care categories. It operates through the following segments: Beauty and Personal Care, Foods and Refreshment, and Home Care. The Beauty and Personal Care segment covers the sales of skin and hair care products, deodorants and oral care products. The Foods and Refreshment segment includes the sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads. The Home Care segment is in charge of the sales of home care products such as powders, liquids and capsules, soap bars, and a wide range of cleaning products. The company was founded on November 9, 1927 and is headquartered in Rotterdam, Netherlands. | Distribution Services |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
- Stock Market
- Insiders
- Hans J. W. de Haard
